Literature DB >> 1744590

Conversion of a self peptide sequence into a Kd-restricted neo-antigen by a Tyr substitution.

F Healy1, C Drouet, P Romero, C Jaulin, J L Maryanski.   

Abstract

We have previously found that a Tyr residue was critical for the interaction of peptides with the Kd molecule, and therefore may be acting as an anchor residue. In the present report we show that it is possible to convert a self peptide sequence into a Kd-restricted neo-antigen by a single Tyr substitution at position 2 of the peptide. This supports the idea that Tyr is a critical element in the binding motif of Kd-restricted peptides and is a finding that could also prove useful for vaccine development.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1744590      PMCID: PMC2119022          DOI: 10.1084/jem.174.6.1657

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

Review 1.  Synthetic T and B cell recognition sites: implications for vaccine development.

Authors:  D R Milich
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

2.  The identification of tyrosine as a common key residue in unrelated H-2Kd restricted antigenic peptides.

Authors:  J L Maryanski; P Romero; A Van Pel; T Boon; F R Salemme; J C Cerottini; G Corradin
Journal:  Int Immunol       Date:  1991-10       Impact factor: 4.823

3.  Structure of the gene of tum- transplantation antigen P91A: the mutated exon encodes a peptide recognized with Ld by cytolytic T cells.

Authors:  C Lurquin; A Van Pel; B Mariamé; E De Plaen; J P Szikora; C Janssens; M J Reddehase; J Lejeune; T Boon
Journal:  Cell       Date:  1989-07-28       Impact factor: 41.582

Review 4.  Antigen recognition by class I-restricted T lymphocytes.

Authors:  A Townsend; H Bodmer
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

5.  The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens.

Authors:  P J Bjorkman; M A Saper; B Samraoui; W S Bennett; J L Strominger; D C Wiley
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

Review 6.  Genes coding for T-cell-defined tum transplantation antigens: point mutations, antigenic peptides, and subgenic expression.

Authors:  T Boon; A Van Pel; E De Plaen; P Chomez; C Lurquin; J P Szikora; C Sibille; B Mariamé; B Van den Eynde; B Lethé
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1989

7.  H2-restricted recognition of cloned HLA class I gene products expressed in mouse cells.

Authors:  J L Maryanski; R S Accolla; B Jordan
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

8.  Structure of the human class I histocompatibility antigen, HLA-A2.

Authors:  P J Bjorkman; M A Saper; B Samraoui; W S Bennett; J L Strominger; D C Wiley
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

9.  Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response.

Authors:  J L Maryanski; J Van Snick; J C Cerottini; T Boon
Journal:  Eur J Immunol       Date:  1982-05       Impact factor: 5.532

10.  Positive selection determines T cell receptor V beta 14 gene usage by CD8+ T cells.

Authors:  N S Liao; J Maltzman; D H Raulet
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

View more
  4 in total

1.  Induction in transgenic mice of HLA-A2.1-restricted cytotoxic T cells specific for a peptide sequence from a mutated p21ras protein.

Authors:  P Escobar; Z Yu; A Terskikh; N Holmes; G Corradin; J P Mach; F Healy
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

2.  T helper cell recognition of muscle acetylcholine receptor in myasthenia gravis. Epitopes on the gamma and delta subunits.

Authors:  A A Manfredi; M P Protti; M W Dalton; J F Howard; B M Conti-Tronconi
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

Review 3.  The role of the immune system in anti-tumour responses. Potential for drug therapy.

Authors:  S Dermime; J Barrett; C Gambacorti-Passerini
Journal:  Drugs Aging       Date:  1995-10       Impact factor: 3.923

4.  Recognition of an immunoglobulin VH epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes.

Authors:  W Cao; B A Myers-Powell; T J Braciale
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.